MX2007005124A - Composiciones farmaceuticas espontaneamente dispersables. - Google Patents

Composiciones farmaceuticas espontaneamente dispersables.

Info

Publication number
MX2007005124A
MX2007005124A MX2007005124A MX2007005124A MX2007005124A MX 2007005124 A MX2007005124 A MX 2007005124A MX 2007005124 A MX2007005124 A MX 2007005124A MX 2007005124 A MX2007005124 A MX 2007005124A MX 2007005124 A MX2007005124 A MX 2007005124A
Authority
MX
Mexico
Prior art keywords
pharmaceutical compositions
dispersible pharmaceutical
spontaneously dispersible
solid
room temperature
Prior art date
Application number
MX2007005124A
Other languages
English (en)
Spanish (es)
Inventor
Madhusudhan Pudipeddi
Alan Edward Royce
Ping Li
Abu T M Serajuddin
Barbara Luckel
Sara Royce Hynes
Michael Ambuhl
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MX2007005124A publication Critical patent/MX2007005124A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2007005124A 2004-10-29 2005-10-27 Composiciones farmaceuticas espontaneamente dispersables. MX2007005124A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62334404P 2004-10-29 2004-10-29
US62334504P 2004-10-29 2004-10-29
PCT/US2005/039004 WO2006050123A1 (en) 2004-10-29 2005-10-27 Spontaneously dispersible pharmaceutical compositions

Publications (1)

Publication Number Publication Date
MX2007005124A true MX2007005124A (es) 2007-06-22

Family

ID=35876536

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007005124A MX2007005124A (es) 2004-10-29 2005-10-27 Composiciones farmaceuticas espontaneamente dispersables.

Country Status (9)

Country Link
US (1) US20080064760A1 (cg-RX-API-DMAC7.html)
EP (1) EP1807049A1 (cg-RX-API-DMAC7.html)
JP (1) JP2008518931A (cg-RX-API-DMAC7.html)
KR (1) KR20070069172A (cg-RX-API-DMAC7.html)
AU (1) AU2005302501A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0518239A2 (cg-RX-API-DMAC7.html)
CA (1) CA2578854A1 (cg-RX-API-DMAC7.html)
MX (1) MX2007005124A (cg-RX-API-DMAC7.html)
WO (1) WO2006050123A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101516346B (zh) * 2006-09-26 2012-05-23 株式会社三养社 水不溶性喜树碱衍生物的亚微粒纳米颗粒及其制备方法
EP2111217A2 (en) * 2006-12-05 2009-10-28 Novartis AG Microemulsion dosage forms of valsartan and methods of making the same
WO2008092084A2 (en) 2007-01-26 2008-07-31 Centocor, Inc. Injectable non-aqueous suspension with high concentration of therapeutic agent
CA2798180A1 (en) 2010-05-03 2011-11-10 Teikoku Pharma Usa, Inc. Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU215966B (hu) * 1994-11-21 1999-07-28 BIOGAL Gyógyszergyár Rt. Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum
EP0969856B1 (en) * 1997-03-12 2005-01-05 Abbott Laboratories Hydrophilic binary systems for the administration of cyclosporine
ID25908A (id) * 1998-03-06 2000-11-09 Novartis Ag Prakonsentrat-prakonsentrat emulsi yang mengandung siklosporin atau makrolida
US20020102301A1 (en) * 2000-01-13 2002-08-01 Joseph Schwarz Pharmaceutical solid self-emulsifying composition for sustained delivery of biologically active compounds and the process for preparation thereof
US6828301B2 (en) * 2002-02-07 2004-12-07 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for hepatitis C viral protease inhibitors
WO2004047673A2 (en) * 2002-11-21 2004-06-10 Novacea, Inc. Treatment of liver disease with active vitamin d compounds

Also Published As

Publication number Publication date
EP1807049A1 (en) 2007-07-18
US20080064760A1 (en) 2008-03-13
AU2005302501A1 (en) 2006-05-11
BRPI0518239A2 (pt) 2008-11-11
JP2008518931A (ja) 2008-06-05
CA2578854A1 (en) 2006-05-11
KR20070069172A (ko) 2007-07-02
WO2006050123A1 (en) 2006-05-11

Similar Documents

Publication Publication Date Title
WO2001076561A3 (en) Pharmaceutical compositions
WO2002067902A3 (en) Modulation of release from dry powder formulations
DK1083884T3 (da) Fremgangsmåde til stabilisering af polyvinylpyrrolidonsammensætninger
NO20025621D0 (no) Farmasöytisk sammensetning med vedvarende frigjöring for parenteral administrasjon av hydrofile forbindelser
WO2008067164A3 (en) Solid pharmaceutical dosage formulations
DK1183014T3 (da) Smagsmaskerede orale farmaceutiske sammensætninger med kontrolleret frigivelse
WO2008094834A3 (en) Multi-functional drug carriers
NO20064094L (no) Partikler
WO2001091725A3 (en) Biologically useful polyphosphates
PT1401501E (pt) Composicoes farmaceuticas orais com libertacao modificada do ingrediente activo
PL1663216T3 (pl) Kompozycje o zmodyfikowanym uwalnianiu zawierające takrolimus
WO2002089773A3 (en) Pharmaceutical compositions comprising cyclosporin
ATE293995T1 (de) Pharmazeutische zusammensetzungen, die wirkstoffabsorptionsfördernde verbindungen enthalten
WO2003000226A3 (en) Pharmaceutical compositions containing polymer and drug assemblies
EP1708719A4 (en) AQUEOUS PHARMACEUTICAL COMPOSITIONS OF 2,6-DIISOPROPYLPHENOL (PROPOFOL) AND THEIR USE
WO2008085556A3 (en) Surfactant-free nanoparticles for drug delivery
DE602005008589D1 (de) Biologisch abbaubare pfropfcopolymere
UA88300C2 (ru) Гидрогелевые композиции, которые содержат интерферон
WO2007100382A3 (en) Orally administrable gallium compositions and method of use
AU2001235783A1 (en) Therapeutic compositions for pulmonary delivery
MX2007005124A (es) Composiciones farmaceuticas espontaneamente dispersables.
AR064104A1 (es) Formas de dosificacion en microemulsion de valsartan, y metodos para elaborarlas
IL171875A0 (en) Pioglitazone salts,such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same
NO20076120L (no) Stabile nanopartikkelformuleringer
BR0206960A (pt) Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose

Legal Events

Date Code Title Description
FA Abandonment or withdrawal